Pfizer Inc. (PFE) Q2 2022 Earnings Results

Pfizer Beats on EPS, Stock Down 2.37%

Pfizer's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 2.37%, likely due to a lack of updated guidance and broader market conditions. Investors may be cautious as the company navigates future uncertainties without clear direction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.04	N/A	+16.44%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the earnings per share results, highlighting their commitment to long-term goals despite not offering new guidance.

We are pleased with our EPS performance this quarter.

While we did not provide updated guidance, we remain focused on our long-term strategies.

Pfizer Beats on EPS, Stock Down 2.37%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 2.37%

Key numbers

Management commentary